-
1
-
-
79952284127
-
Hallmarks of cancer: the next generation
-
Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
-
(2011)
Cell
, vol.144
, Issue.5
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
3
-
-
33645739790
-
Tumor stroma and regulation of cancer development
-
Tlsty TD, Coussens LM: Tumor stroma and regulation of cancer development. Annu Rev Pathol 2006, 1:119-150.
-
(2006)
Annu Rev Pathol
, vol.1
, pp. 119-150
-
-
Tlsty, T.D.1
Coussens, L.M.2
-
4
-
-
0014887939
-
The concept of immunological surveillance
-
Burnet FM: The concept of immunological surveillance. Prog Exp Tumor Res 1957, 13:1-27.
-
(1957)
Prog Exp Tumor Res
, vol.13
, pp. 1-27
-
-
Burnet, F.M.1
-
5
-
-
1642577616
-
Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution
-
Klein G, Klein E: Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution. Proc Natl Acad Sci U S A 1977, 74(5):2121-2125.
-
(1977)
Proc Natl Acad Sci U S A
, vol.74
, Issue.5
, pp. 2121-2125
-
-
Klein, G.1
Klein, E.2
-
6
-
-
79953151458
-
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
-
Schreiber RD, Old LJ, Smyth MJ: Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331(6024):1565-1570.
-
(2011)
Science
, vol.331
, Issue.6024
, pp. 1565-1570
-
-
Schreiber, R.D.1
Old, L.J.2
Smyth, M.J.3
-
7
-
-
0035953308
-
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity
-
Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD: IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001, 410(6832):1107-1111.
-
(2001)
Nature
, vol.410
, Issue.6832
, pp. 1107-1111
-
-
Shankaran, V.1
Ikeda, H.2
Bruce, A.T.3
White, J.M.4
Swanson, P.E.5
Old, L.J.6
Schreiber, R.D.7
-
8
-
-
79953059789
-
Natural innate and adaptive immunity to cancer
-
Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ: Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011, 29:235-271.
-
(2011)
Annu Rev Immunol
, vol.29
, pp. 235-271
-
-
Vesely, M.D.1
Kershaw, M.H.2
Schreiber, R.D.3
Smyth, M.J.4
-
9
-
-
36849010167
-
Adaptive immunity maintains occult cancer in an equilibrium state
-
Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD: Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007, 450(7171):903-907.
-
(2007)
Nature
, vol.450
, Issue.7171
, pp. 903-907
-
-
Koebel, C.M.1
Vermi, W.2
Swann, J.B.3
Zerafa, N.4
Rodig, S.J.5
Old, L.J.6
Smyth, M.J.7
Schreiber, R.D.8
-
10
-
-
0028500836
-
Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors
-
Dighe AS, Richards E, Old LJ, Schreiber RD: Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity 1994, 1(6):447-456.
-
(1994)
Immunity
, vol.1
, Issue.6
, pp. 447-456
-
-
Dighe, A.S.1
Richards, E.2
Old, L.J.3
Schreiber, R.D.4
-
11
-
-
0025604195
-
Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity
-
Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E: Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 1990, 50(24):7820-7825.
-
(1990)
Cancer Res
, vol.50
, Issue.24
, pp. 7820-7825
-
-
Gansbacher, B.1
Bannerji, R.2
Daniels, B.3
Zier, K.4
Cronin, K.5
Gilboa, E.6
-
12
-
-
0027407938
-
Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma
-
Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantstein T, Blankenstein T: Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci U S A 1993, 90(7):2774-2778.
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, Issue.7
, pp. 2774-2778
-
-
Hock, H.1
Dorsch, M.2
Kunzendorf, U.3
Qin, Z.4
Diamantstein, T.5
Blankenstein, T.6
-
13
-
-
0028219791
-
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
-
Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994, 369(6475):31-37.
-
(1994)
Nature
, vol.369
, Issue.6475
, pp. 31-37
-
-
Kagi, D.1
Ledermann, B.2
Burki, K.3
Seiler, P.4
Odermatt, B.5
Olsen, K.J.6
Podack, E.R.7
Zinkernagel, R.M.8
Hengartner, H.9
-
14
-
-
0034605122
-
Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma
-
Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI, Trapani JA: Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 2000, 192(5):755-760.
-
(2000)
J Exp Med
, vol.192
, Issue.5
, pp. 755-760
-
-
Smyth, M.J.1
Thia, K.Y.2
Street, S.E.3
MacGregor, D.4
Godfrey, D.I.5
Trapani, J.A.6
-
15
-
-
34347231323
-
Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma
-
Street SE, Zerafa N, Iezzi M, Westwood JA, Stagg J, Musiani P, Smyth MJ: Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma. Cancer Res 2007, 67(11):5454-5460.
-
(2007)
Cancer Res
, vol.67
, Issue.11
, pp. 5454-5460
-
-
Street, S.E.1
Zerafa, N.2
Iezzi, M.3
Westwood, J.A.4
Stagg, J.5
Musiani, P.6
Smyth, M.J.7
-
16
-
-
0029804782
-
Decreased tumor surveillance in perforin-deficient mice
-
van den Broek ME, Kagi D, Ossendorp F, Toes R, Vamvakas S, Lutz WK, Melief CJ, Zinkernagel RM, Hengartner H: Decreased tumor surveillance in perforin-deficient mice. J Exp Med 1996, 184(5):1781-1790.
-
(1996)
J Exp Med
, vol.184
, Issue.5
, pp. 1781-1790
-
-
van den Broek, M.E.1
Kagi, D.2
Ossendorp, F.3
Toes, R.4
Vamvakas, S.5
Lutz, W.K.6
Melief, C.J.7
Zinkernagel, R.M.8
Hengartner, H.9
-
17
-
-
24344436369
-
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
-
Willimsky G, Blankenstein T: Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 2005, 437(7055):141-146.
-
(2005)
Nature
, vol.437
, Issue.7055
, pp. 141-146
-
-
Willimsky, G.1
Blankenstein, T.2
-
18
-
-
79960451984
-
T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-beta1 cytokine
-
Donkor MK, Sarkar A, Savage PA, Franklin RA, Johnson LK, Jungbluth AA, Allison JP, Li MO: T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-beta1 cytokine. Immunity 2011, 35(1):123-134.
-
(2011)
Immunity
, vol.35
, Issue.1
, pp. 123-134
-
-
Donkor, M.K.1
Sarkar, A.2
Savage, P.A.3
Franklin, R.A.4
Johnson, L.K.5
Jungbluth, A.A.6
Allison, J.P.7
Li, M.O.8
-
19
-
-
38149035080
-
Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes
-
Savage PA, Vosseller K, Kang C, Larimore K, Riedel E, Wojnoonski K, Jungbluth AA, Allison JP: Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes. Science 2008, 319(5860):215-220.
-
(2008)
Science
, vol.319
, Issue.5860
, pp. 215-220
-
-
Savage, P.A.1
Vosseller, K.2
Kang, C.3
Larimore, K.4
Riedel, E.5
Wojnoonski, K.6
Jungbluth, A.A.7
Allison, J.P.8
-
20
-
-
33646179699
-
Human T cell responses against melanoma
-
Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P: Human T cell responses against melanoma. Annu Rev Immunol 2006, 24:175-208.
-
(2006)
Annu Rev Immunol
, vol.24
, pp. 175-208
-
-
Boon, T.1
Coulie, P.G.2
Van den Eynde, B.J.3
van der Bruggen, P.4
-
21
-
-
0033056073
-
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
-
Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD et al: Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 1999, 5(6):677-685.
-
(1999)
Nat Med
, vol.5
, Issue.6
, pp. 677-685
-
-
Lee, P.P.1
Yee, C.2
Savage, P.A.3
Fong, L.4
Brockstedt, D.5
Weber, J.S.6
Johnson, D.7
Swetter, S.8
Thompson, J.9
Greenberg, P.D.10
-
22
-
-
34547689270
-
Do autochthonous tumors interfere with effector T cell responses?
-
Blankenstein T: Do autochthonous tumors interfere with effector T cell responses? Semin Cancer Biol 2007, 17(4):267-274
-
(2007)
Semin Cancer Biol
, vol.17
, Issue.4
, pp. 267-274
-
-
Blankenstein, T.1
-
24
-
-
63049104211
-
Microenvironmental regulation of metastasis
-
Joyce JA, Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9(4):239-252.
-
(2009)
Nat Rev Cancer
, vol.9
, Issue.4
, pp. 239-252
-
-
Joyce, J.A.1
Pollard, J.W.2
-
25
-
-
46949109577
-
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
-
Willimsky G, Czeh M, Loddenkemper C, Gellermann J, Schmidt K, Wust P, Stein H, Blankenstein T: Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. J Exp Med 2008, 205(7):1687-1700.
-
(2008)
J Exp Med
, vol.205
, Issue.7
, pp. 1687-1700
-
-
Willimsky, G.1
Czeh, M.2
Loddenkemper, C.3
Gellermann, J.4
Schmidt, K.5
Wust, P.6
Stein, H.7
Blankenstein, T.8
-
26
-
-
0842333147
-
Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients
-
Buck MB, Fritz P, Dippon J, Zugmaier G, Knabbe C: Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients. Clin Cancer Res 2004, 10(2):491-498.
-
(2004)
Clin Cancer Res
, vol.10
, Issue.2
, pp. 491-498
-
-
Buck, M.B.1
Fritz, P.2
Dippon, J.3
Zugmaier, G.4
Knabbe, C.5
-
27
-
-
0021173481
-
Normal embryo fibroblasts release transforming growth factors in a latent form
-
Lawrence DA, Pircher R, Kryceve-Martinerie C, Jullien P: Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 1984, 121(1):184-188.
-
(1984)
J Cell Physiol
, vol.121
, Issue.1
, pp. 184-188
-
-
Lawrence, D.A.1
Pircher, R.2
Kryceve-Martinerie, C.3
Jullien, P.4
-
28
-
-
33646164362
-
Transforming growth factor-beta regulation of immune responses
-
Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA: Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006, 24:99-146.
-
(2006)
Annu Rev Immunol
, vol.24
, pp. 99-146
-
-
Li, M.O.1
Wan, Y.Y.2
Sanjabi, S.3
Robertson, A.K.4
Flavell, R.A.5
-
29
-
-
33646562542
-
The logic of TGFbeta signaling
-
Massague J, Gomis RR: The logic of TGFbeta signaling. FEBS Lett 2006, 580(12):2811-2820.
-
(2006)
FEBS Lett
, vol.580
, Issue.12
, pp. 2811-2820
-
-
Massague, J.1
Gomis, R.R.2
-
30
-
-
0027466618
-
Transforming growth factor-beta: latent forms, binding proteins and receptors
-
Miyazono K, Ichijo H, Heldin CH: Transforming growth factor-beta: latent forms, binding proteins and receptors. Growth Factors 1993, 8(1):11-22.
-
(1993)
Growth Factors
, vol.8
, Issue.1
, pp. 11-22
-
-
Miyazono, K.1
Ichijo, H.2
Heldin, C.H.3
-
31
-
-
34548208943
-
Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice
-
Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, Proctor JM, Wang Y, Bernstein X, Huang X, Reichardt LF et al: Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007, 449(7160):361-365.
-
(2007)
Nature
, vol.449
, Issue.7160
, pp. 361-365
-
-
Travis, M.A.1
Reizis, B.2
Melton, A.C.3
Masteller, E.4
Tang, Q.5
Proctor, J.M.6
Wang, Y.7
Bernstein, X.8
Huang, X.9
Reichardt, L.F.10
-
32
-
-
48449086316
-
TGF-beta: a master of all T cell trades
-
Li MO, Flavell RA: TGF-beta: a master of all T cell trades. Cell 2008, 134(3):392-404.
-
(2008)
Cell
, vol.134
, Issue.3
, pp. 392-404
-
-
Li, M.O.1
Flavell, R.A.2
-
33
-
-
0034327176
-
Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression
-
Gorelik L, Fields PE, Flavell RA: Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 2000, 165(9):4773-4777.
-
(2000)
J Immunol
, vol.165
, Issue.9
, pp. 4773-4777
-
-
Gorelik, L.1
Fields, P.E.2
Flavell, R.A.3
-
34
-
-
0022465625
-
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth
-
Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS: Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986, 163(5):1037-1050.
-
(1986)
J Exp Med
, vol.163
, Issue.5
, pp. 1037-1050
-
-
Kehrl, J.H.1
Wakefield, L.M.2
Roberts, A.B.3
Jakowlew, S.4
Alvarez-Mon, M.5
Derynck, R.6
Sporn, M.B.7
Fauci, A.S.8
-
35
-
-
13544274450
-
Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3
-
McKarns SC, Schwartz RH: Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3. J Immunol 2005, 174(4):2071-2083.
-
(2005)
J Immunol
, vol.174
, Issue.4
, pp. 2071-2083
-
-
McKarns, S.C.1
Schwartz, R.H.2
-
36
-
-
0037029649
-
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease
-
Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H, Mizoguchi A, Mizoguchi E, Mudter J, Galle PR et al: The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 2002, 195(9):1129-1143.
-
(2002)
J Exp Med
, vol.195
, Issue.9
, pp. 1129-1143
-
-
Neurath, M.F.1
Weigmann, B.2
Finotto, S.3
Glickman, J.4
Nieuwenhuis, E.5
Iijima, H.6
Mizoguchi, A.7
Mizoguchi, E.8
Mudter, J.9
Galle, P.R.10
-
37
-
-
77953267301
-
Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development
-
Ouyang W, Beckett O, Ma Q, Li MO: Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 2010, 32(5):642-653.
-
(2010)
Immunity
, vol.32
, Issue.5
, pp. 642-653
-
-
Ouyang, W.1
Beckett, O.2
Ma, Q.3
Li, M.O.4
-
38
-
-
0038353468
-
Reversal of tumor-induced immunosuppression by TGF-beta inhibitors
-
Wojtowicz-Praga S: Reversal of tumor-induced immunosuppression by TGF-beta inhibitors. Invest New Drugs 2003, 21(1):21-32.
-
(2003)
Invest New Drugs
, vol.21
, Issue.1
, pp. 21-32
-
-
Wojtowicz-Praga, S.1
-
39
-
-
58149236744
-
Roles of TGFbeta in metastasis
-
Padua D, Massague J: Roles of TGFbeta in metastasis. Cell Res 2009, 19(1):89-102.
-
(2009)
Cell Res
, vol.19
, Issue.1
, pp. 89-102
-
-
Padua, D.1
Massague, J.2
-
40
-
-
0242499448
-
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer
-
Siegel PM, Massague J: Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003, 3(11):807-821.
-
(2003)
Nat Rev Cancer
, vol.3
, Issue.11
, pp. 807-821
-
-
Siegel, P.M.1
Massague, J.2
-
41
-
-
70349742484
-
Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model
-
Pu H, Collazo J, Jones E, Gayheart D, Sakamoto S, Vogt A, Mitchell B, Kyprianou N: Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model. Cancer Res 2009, 69(18):7366-7374.
-
(2009)
Cancer Res
, vol.69
, Issue.18
, pp. 7366-7374
-
-
Pu, H.1
Collazo, J.2
Jones, E.3
Gayheart, D.4
Sakamoto, S.5
Vogt, A.6
Mitchell, B.7
Kyprianou, N.8
-
42
-
-
33745515023
-
Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer
-
Bierie B, Moses HL: Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006, 6(7):506-520.
-
(2006)
Nat Rev Cancer
, vol.6
, Issue.7
, pp. 506-520
-
-
Bierie, B.1
Moses, H.L.2
-
43
-
-
30944444113
-
Alterations in components of the TGF-beta superfamily signaling pathways in human cancer
-
Levy L, Hill CS: Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 2006, 17(1-2):41-58.
-
(2006)
Cytokine Growth Factor Rev
, vol.17
, Issue.1-2
, pp. 41-58
-
-
Levy, L.1
Hill, C.S.2
-
44
-
-
0037379315
-
Tumor-derived TGF-beta reduces the efficacy of dendritic cell/ tumor fusion vaccine
-
Kao JY, Gong Y, Chen CM, Zheng QD, Chen JJ: Tumor-derived TGF-beta reduces the efficacy of dendritic cell/ tumor fusion vaccine. J Immunol 2003, 170(7):3806-3811.
-
(2003)
J Immunol
, vol.170
, Issue.7
, pp. 3806-3811
-
-
Kao, J.Y.1
Gong, Y.2
Chen, C.M.3
Zheng, Q.D.4
Chen, J.J.5
-
45
-
-
45549085803
-
An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments
-
Nam JS, Terabe M, Mamura M, Kang MJ, Chae H, Stuelten C, Kohn E, Tang B, Sabzevari H, Anver MR et al: An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res 2008, 68(10):3835-3843.
-
(2008)
Cancer Res
, vol.68
, Issue.10
, pp. 3835-3843
-
-
Nam, J.S.1
Terabe, M.2
Mamura, M.3
Kang, M.J.4
Chae, H.5
Stuelten, C.6
Kohn, E.7
Tang, B.8
Sabzevari, H.9
Anver, M.R.10
-
46
-
-
20144387943
-
Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer
-
Zhang Q, Yang X, Pins M, Javonovic B, Kuzel T, Kim SJ, Parijs LV, Greenberg NM, Liu V, Guo Y et al: Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer. Cancer Res 2005, 65(5):1761-1769.
-
(2005)
Cancer Res
, vol.65
, Issue.5
, pp. 1761-1769
-
-
Zhang, Q.1
Yang, X.2
Pins, M.3
Javonovic, B.4
Kuzel, T.5
Kim, S.J.6
Parijs, L.V.7
Greenberg, N.M.8
Liu, V.9
Guo, Y.10
-
47
-
-
33748293112
-
Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle
-
Zhang Q, Yang XJ, Kundu SD, Pins M, Javonovic B, Meyer R, Kim SJ, Greenberg NM, Kuzel T, Meagher R et al: Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle. Mol Cancer Ther 2006, 5(7):1733-1743.
-
(2006)
Mol Cancer Ther
, vol.5
, Issue.7
, pp. 1733-1743
-
-
Zhang, Q.1
Yang, X.J.2
Kundu, S.D.3
Pins, M.4
Javonovic, B.5
Meyer, R.6
Kim, S.J.7
Greenberg, N.M.8
Kuzel, T.9
Meagher, R.10
-
48
-
-
47549090432
-
TGFbeta in Cancer
-
Massague J: TGFbeta in Cancer. Cell 2008, 134(2):215-230.
-
(2008)
Cell
, vol.134
, Issue.2
, pp. 215-230
-
-
Massague, J.1
-
49
-
-
0024555682
-
Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice
-
Thompson NL, Flanders KC, Smith JM, Ellingsworth LR, Roberts AB, Sporn MB: Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice. J Cell Biol 1989, 108(2):661-669.
-
(1989)
J Cell Biol
, vol.108
, Issue.2
, pp. 661-669
-
-
Thompson, N.L.1
Flanders, K.C.2
Smith, J.M.3
Ellingsworth, L.R.4
Roberts, A.B.5
Sporn, M.B.6
-
50
-
-
37349100945
-
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis
-
Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC et al: Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008, 13(1):23-35.
-
(2008)
Cancer Cell
, vol.13
, Issue.1
, pp. 23-35
-
-
Yang, L.1
Huang, J.2
Ren, X.3
Gorska, A.E.4
Chytil, A.5
Aakre, M.6
Carbone, D.P.7
Matrisian, L.M.8
Richmond, A.9
Lin, P.C.10
-
51
-
-
5644248080
-
RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo
-
Friese MA, Wischhusen J, Wick W, Weiler M, Eisele G, Steinle A, Weller M: RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res 2004, 64(20):7596-7603.
-
(2004)
Cancer Res
, vol.64
, Issue.20
, pp. 7596-7603
-
-
Friese, M.A.1
Wischhusen, J.2
Wick, W.3
Weiler, M.4
Eisele, G.5
Steinle, A.6
Weller, M.7
-
52
-
-
33847337912
-
Tumor evasion of the immune system by converting CD4+CD25-T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta
-
Liu VC, Wong LY, Jang T, Shah AH, Park I, Yang X, Zhang Q, Lonning S, Teicher BA, Lee C: Tumor evasion of the immune system by converting CD4+CD25-T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol 2007, 178(5):2883-2892.
-
(2007)
J Immunol
, vol.178
, Issue.5
, pp. 2883-2892
-
-
Liu, V.C.1
Wong, L.Y.2
Jang, T.3
Shah, A.H.4
Park, I.5
Yang, X.6
Zhang, Q.7
Lonning, S.8
Teicher, B.A.9
Lee, C.10
-
53
-
-
0025055406
-
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance
-
Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA: A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc Natl Acad Sci U S A 1990, 87(4):1486-1490.
-
(1990)
Proc Natl Acad Sci U S A
, vol.87
, Issue.4
, pp. 1486-1490
-
-
Torre-Amione, G.1
Beauchamp, R.D.2
Koeppen, H.3
Park, B.H.4
Schreiber, H.5
Moses, H.L.6
Rowley, D.A.7
-
54
-
-
27644457376
-
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
-
Thomas DA, Massague J: TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 2005, 8(5):369-380.
-
(2005)
Cancer Cell
, vol.8
, Issue.5
, pp. 369-380
-
-
Thomas, D.A.1
Massague, J.2
-
55
-
-
0030658840
-
Cre-mediated gene deletion in the mammary gland
-
Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L: Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 1997, 25(21):4323-4330.
-
(1997)
Nucleic Acids Res
, vol.25
, Issue.21
, pp. 4323-4330
-
-
Wagner, K.U.1
Wall, R.J.2
St-Onge, L.3
Gruss, P.4
Wynshaw-Boris, A.5
Garrett, L.6
Li, M.7
Furth, P.A.8
Hennighausen, L.9
-
56
-
-
0026587657
-
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease
-
Guy CT, Cardiff RD, Muller WJ: Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992, 12(3):954-961.
-
(1992)
Mol Cell Biol
, vol.12
, Issue.3
, pp. 954-961
-
-
Guy, C.T.1
Cardiff, R.D.2
Muller, W.J.3
-
57
-
-
41149157649
-
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4
-
Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massague J: TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008, 133(1):66-77.
-
(2008)
Cell
, vol.133
, Issue.1
, pp. 66-77
-
-
Padua, D.1
Zhang, X.H.2
Wang, Q.3
Nadal, C.4
Gerald, W.L.5
Gomis, R.R.6
Massague, J.7
-
58
-
-
77954557286
-
TGFbeta and cancer metastasis: an inflammation link
-
Yang L: TGFbeta and cancer metastasis: an inflammation link. Cancer Metastasis Rev 2010, 29(2):263-271.
-
(2010)
Cancer Metastasis Rev
, vol.29
, Issue.2
, pp. 263-271
-
-
Yang, L.1
-
59
-
-
0034614637
-
The hallmarks of cancer
-
Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100(1):57-70.
-
(2000)
Cell
, vol.100
, Issue.1
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
61
-
-
34147211281
-
Lung metastasis genes couple breast tumor size and metastatic spread
-
Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, Nuyten D, Kreike B, Zhang Y, Wang Y, Ishwaran H et al: Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A 2007, 104(16):6740-6745.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, Issue.16
, pp. 6740-6745
-
-
Minn, A.J.1
Gupta, G.P.2
Padua, D.3
Bos, P.4
Nguyen, D.X.5
Nuyten, D.6
Kreike, B.7
Zhang, Y.8
Wang, Y.9
Ishwaran, H.10
-
62
-
-
0033910732
-
Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement
-
Dalton LW, Pinder SE, Elston CE, Ellis IO, Page DL, Dupont WD, Blamey RW: Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol 2000, 13(7):730-735.
-
(2000)
Mod Pathol
, vol.13
, Issue.7
, pp. 730-735
-
-
Dalton, L.W.1
Pinder, S.E.2
Elston, C.E.3
Ellis, I.O.4
Page, D.L.5
Dupont, W.D.6
Blamey, R.W.7
-
63
-
-
33748489545
-
TGF-beta T-cell tolerance and immunotherapy of autoimmune diseases and cancer
-
Li MO, Flavell RA: TGF-beta, T-cell tolerance and immunotherapy of autoimmune diseases and cancer. Expert Rev Clin Immunol 2006, 2(2):257-265.
-
(2006)
Expert Rev Clin Immunol
, vol.2
, Issue.2
, pp. 257-265
-
-
Li, M.O.1
Flavell, R.A.2
-
64
-
-
33644868712
-
Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma
-
Wick W, Naumann U, Weller M: Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 2006, 12(3):341-349.
-
(2006)
Curr Pharm Des
, vol.12
, Issue.3
, pp. 341-349
-
-
Wick, W.1
Naumann, U.2
Weller, M.3
-
65
-
-
0025632985
-
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution
-
Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB: Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 1990, 86(6):1976-1984.
-
(1990)
J Clin Invest
, vol.86
, Issue.6
, pp. 1976-1984
-
-
Wakefield, L.M.1
Winokur, T.S.2
Hollands, R.S.3
Christopherson, K.4
Levinson, A.D.5
Sporn, M.B.6
-
66
-
-
47949099628
-
Modes of resistance to anti-angiogenic therapy
-
Bergers G, Hanahan D: Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008, 8(8):592-603.
-
(2008)
Nat Rev Cancer
, vol.8
, Issue.8
, pp. 592-603
-
-
Bergers, G.1
Hanahan, D.2
-
67
-
-
80054875641
-
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
-
Sharma P, Wagner K, Wolchok JD, Allison JP: Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat Rev Cancer 2011, 11(11):805-812.
-
(2011)
Nat Rev Cancer
, vol.11
, Issue.11
, pp. 805-812
-
-
Sharma, P.1
Wagner, K.2
Wolchok, J.D.3
Allison, J.P.4
-
68
-
-
34248592104
-
T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation
-
Li MO, Wan YY, Flavell RA: T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation. Immunity 2007, 26(5):579-591.
-
(2007)
Immunity
, vol.26
, Issue.5
, pp. 579-591
-
-
Li, M.O.1
Wan, Y.Y.2
Flavell, R.A.3
-
69
-
-
0142244181
-
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases
-
Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW: Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003, 163(5):2113-2126
-
(2003)
Am J Pathol
, vol.163
, Issue.5
, pp. 2113-2126
-
-
Lin, E.Y.1
Jones, J.G.2
Li, P.3
Zhu, L.4
Whitney, K.D.5
Muller, W.J.6
Pollard, J.W.7
|